PMDIPsychemedics Corp.
Price Chart
Loading chart...
About Psychemedics Corp. (PMDI)
Psychemedics Corp. (PMDI) is a Diagnostics & Research company headquartered in Dallas, TX, United States whose shares trade over-the-counter on the Pink tier.
Psychemedics Corporation, together with its subsidiaries, engages in the provision of testing services for the detection of drugs of abuse and other health markers through the analysis of hair samples in the United States and internationally. It offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, and Adderall; opioids, such as heroin metabolite, morphine, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine; synthetic cannabinoids comprising K2, Spice, and Blaze; benzodiazepines consisting of Xanax, Valium, and Ativan; and nicotine, fentanyl and fentanyl analogs, and alcohol. The company's testing results provide quantitative information that could indicate the approximate amount of drug ingested, as well as historical data that could show a pattern of individual drug use over a longer period-of-time. It offers its services to employers for job applicant and employee testing; and treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use.
Products and services
Testing services for the detection of drugs of abuse and other health markers through the analysis of hair samples in the United States and internationally.
PMDI key facts
- Ticker symbol
- PMDI
- Market tier
- Pink
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Headquarters
- Dallas, TX, United States
- Country of incorporation
- US
- Year of incorporation
- 1986
- Employees
- 101
- Estimated market cap
- $13.81M (as of Apr 10, 2025)
- Shares outstanding
- 6,109,502
- Reporting standard
- Alternative Reporting Standard
- Audit status
- Audited
- Fiscal year end
- 12/31
Psychemedics Corp. leadership
- Brian Hullinger — CEO
- Daniella Mehalik — VP, Fin., Secretary
- Adriana Majeski — Accountant
- Shannon Shoemaker — Chief Revenue Officer
Explore more: Diagnostics & Research stocks · Healthcare sector · Pink stocks · OTC stocks starting with P
Press Releases
Loading press releases...
Latest News
Loading news...
Key Statistics
Major Holders
Loading...
Loading modules...
AI-Powered Stock Analysis
Get a concise 600-word investment analysis for Psychemedics Corp. (PMDI) prioritizing the most recent news and developments. Our AI focuses on today's breaking news first, then recent company developments, business updates, strategic initiatives, and current market positioning. Get the most relevant and current analysis available.
Still in beta - Please send feedback after generating your analysis to help us improve!
Smart investment analysis prioritizing breaking news, then recent company developments and strategic insights - completely free!
More Diagnostics & Research Companies on OTC Markets
Other OTC-traded companies in Diagnostics & Research:
Investor Reviews
Investor Reviews (0)
Loading reviews...
Company Profile
Loading company profile data...
Contact Information
Company Leadership
Chief Executive Officer
Company Officers
Social Media
Business Details
Stock Details
Loading modules...